Dr. Shidong Jia
Founder and CEO
Presentation: Developing an Advanced Customer Optimization Strategy to Drive Business Growth
Dr. Shidong Jia is the Founder and CEO of Predicine Holdings Ltd, an international precision medicine organization that is committed to developing innovative diagnostics, therapeutics and big data in cancer and other serious diseases. The company operates in California, USA and Shanghai, China.
A former Scientist at Genentech and Novartis, Dr. Jia spearheaded the biomarker strategies and drug & diagnostics co-developments efforts in support of clinical oncology pipeline at various. His previous work identified p110beta as novel drug target for PTEN-deficient tumors (Jia S, et al. Nature, 2008), a finding that laid the foundation for clinical development and testing of p110beta inhibitors in cancers. Currently, Dr. Jia serves as the Editor-in-Chief of "Journal of Circulating Biomarkers".